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1. Introduction 
ES cells can produce any cell type of a living organism while self-renewing, and have been a 
favorable tool for cell engineering, transplantation and regenerative medicine (Wobus and 
Boheler, 2005). There were many issues about the signalling pathways and molecular 
mechanisms of self-renewal and differentiation in ES cells, however, the discussion has not 
realized an appropriate goal yet. Thus, it is important to study the signalling pathways, 
especially in neuronal differentiation, to create a better and novel approach for controlling the 
differentiation process using mouse model ES cells (Sugimoto et al., 2009; Miyazu et al., 2010).   
In mouse ES cells, self-renewal and maintenance of pluripotency requires LIF and bone 
morphogenic proteins (BMPs) (Smith et al., 1988; Williams et al., 1988; Ying et al., 2003). LIF 
belongs to the cytokine interleukin (IL)-6 family which utilizes the common gp130 receptor 
for cellular signaling, and LIF signaling is mediated through a low affinity LIF receptor 
(LIFRβ) which forms a heterodimer with the gp130 upon LIF binding (Hibi et al., 1990; Stahl 
et al., 1994). The formation of a high affinity trimeric complex composed of LIFRβ, gp130, 
and LIF leads to the activation of the janus kinase (JAK)-signal transducers and activators of 
transcription (STAT) pathway and the mitogen-activated protein (MAP) kinase pathway 
(Burdon et al., 2002; Heinrich et al., 2003; Ernst and Jenkins, 2004; Krinstensen et al., 2005). 
The binding of LIF to LIFRβ-gp130 results in the rapid activation of JAK which in turn 
phosphorylates tyrosine residues of LIFRβ and gp130 (Ernst et al., 1996). The 
phosphorylated tyrosine residues act as binding sites for signaling molecules such as a 
transcriptional factor STAT3 and a protein tyrosine phosphatase SHP-2 (Heinrich et al., 
1998). Recruited STAT3 and SHP-2 are also phosphorylated at tyrosine residues. 
Phosphorylation of STAT3 promotes the homodimerization through the interaction of the 
Src homology (SH) 2 domain and the phosphotyrosine domain. The homodimer of STAT3 
translocates to the nucleus and functions as a transcriptional factor (Schindler and Darnell, 
1995; Darnell, 1997). On the other hand, phosphorylation of SHP-2 generates binding sites 
for Grb2 and associates with a scaffold protein Grb2-associated binder protein (Gab) 1. The 
complex subsequently induces the activation of Ras-MAP kinase cascade (Fukada et al., 
1996; Van Vactor et al., 1998). Especially, ERKs, which are members of MAP kinase family 
proteins, are activated by a large number of ligands. The binding of BMP4 to its receptors 
triggers the phosphorylation of Smad1 and activates the expression of inhibitor of 
differentiation (Id) gene family. It is considered that the induction of Id expression through 
Smad1 activation by BMP4 is the critical contribution to the maintenance of pluripotency in 
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ES cells (Ying et al., 2003). Hence, mouse ES cells are maintained in an undifferentiated state 
in vitro with LIF, which activates STAT3 and BMP to induce Id proteins (Niwa et al., 1998; 
Matsuda et al., 1999; Raz et al., 1999; Ying et al., 2003). As described above, the LIF leads to 
the phosphorylation of STAT3 and ERKs. Actually the phosphorylation form of STAT3 is 
detected in undifferentiated ES cells cultured in the medium containing LIF. However, the 
phosphorylation of ERKs does not occur in undifferentiated ES cells. The activation of ERKs 
is considered to be involved in the differentiation process rather than the maintenance of 
undifferentiated state, because the removal of LIF leads to the phosphorylation of ERKs and 
the attenuation of ERKs activation by inhibitor of a MAP/ERK kinase (MEK) activation or 
expression of ERK phosphatases reduced the level of differentiation of ES cells (Burdon et 
al., 1999a). Therefore, in ES cells, it has been considered that LIF predominantly activates 
STAT3 to remain undifferentiated and that the balance of conflicting activation of STAT3 
and ERKs might determine the efficiency of the self-renewal and differentiation (Niwa et al., 
1998; Burdon et al., 1999b). However, the molecular mechanism for balanced activation of 
STAT3 and ERKs in ES cells is not yet clear. We recently found that the dephosphorylation 
of phospho-STAT3 and phosphorylation of ERKs occurred consistently after the removal of 
LIF and that SOCS3, whose expression was regulated by STAT3, might regulate the 
activation of ERK pathway (Miyazu et al., 2010). 
On the other hand, the removal of LIF is known to induce the formation of EB for ES cells.  
The most commonly used approach for neural differentiation from ES cells is the formation 
of EB and the treatment of EB with retinoic acid (Strubing et al., 1995). It has been reported 
that ES cells overexpressing NeuroD2, a basic helix-loop-helix (bHLH) transcriptional factor, 
lead to differentiation to neurons efficiently in the absence of retinoic acid after EB 
formation (Kanda et al., 2004). Because continued culture of EB results in the appearance of 
ectodermal, mesodermal, and endodermal cell types, the differentiation of EB yields a small 
fraction of neural cells. The establishment of differentiation system from ES cells to neurons 
without EB formation is considered to be favorable for the production of neurons in high 
efficiency. The bHLH transcriptional factors are implicated in the regulation of 
differentiation in various cell types (Massari and Murre, 2000). NeuroD2 has been reported 
to play a critical role in the induction of neuronal differentiation, the promotion of neuronal 
survival, and development of thalamocortical communication (Kume et al., 1996; 
McCormick et al., 1996; Yasunami et al., 1996; Farah et al., 2000; Olson et al., 2001; Ince-
Dunn, et al., 2006; Lin et al., 2006; Noda et al., 2006). NeuroD2 has two basic-rich domains; 
one is basic region of bHLH and the other is nuclear localization signal which plays a role of 
protein transduction. In Xenopus laevis embryos the expression of NeuroD2 results in ectopic 
neurogenesis, and in mouse brain NeuroD2 expression starts around embryonic day 11.  
NeuroD2-deficient mice exhibit small brains, ataxia, reduced seizure threshold, defective 
thalamacortical synapses, growth failure, and early death. NeuroD2 also induces the 
differentiation to neurons in mouse neuroblastoma cells, embryonic carcinoma cells, and ES 
cells (Farah et al., 2000; Kanda et al., 2004; Noda et al., 2006).  
Then, we recently established the regulation system of NeuroD2 expression using 
doxycycline in ES cells (Gossen and Bujard, 1992; Gossen and Bujard, 1995). This system was 
useful for studying the role of NeuroD2 in the neuronal differentiation because specific 
transcriptional factors are known to be expressed in a manner consistent with their having a 
regulatory role in the various stages of ES cell development (Sugimoto et al., 2009).  So, in 
this review we will describe focusing mainly on the SOCS3 signalling and expression of 
Neuro D2 in mouse ES cells. 
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2. Materials and methods 
2.1 Cell cultures 
Mouse 129/sv ES cell lines (passage 15, Dainippon Pharmaceutical Corporation, Osaka, 
Japan) were routinely cultured on tissue culture plates (Falcon) coated with 0.1% (v/v) 
gelatin (Dainippon Pharmaceutical Corporation) in KnockoutTM Dulbecco’s modified 
Eagle’s medium (DMEM) (Invitrogen, Scottland) in the presence of 15% (v/v) KnockoutTM 
serum replacement (Invitrogen), 0.1 mM β-mercaptoethanol, 2 mM L-glutamine, 0.1 mM 
non-essential amino acids, 100 units/ml penicillin, 0.1 mg/ml streptomycin, and 1000 
units/ml mouse LIF (Chemicon) in 5% CO2 incubator at 37 ºC (Amano et al., 2006; Sugimoto 
et al., 2009; Miyazu et al., 2010). Cells were trypsinized and replated every 3 days. 
2.2 Western blotting 
To prepare whole cell lysate, collected ES cells were suspended in ice-cold lysis buffer (10 
mM Tris-HCl, pH 7.4, 0.5% Nonidet P-40, 1 mM EDTA, 150 mM NaCl, 1 mM Na3VO4, 0.5 
mM phenylmethylsulfonyl fluoride) and allowed to stand on ice for 30 min. The suspension 
was clarified by centrifugation (14,000 rpm, 20 min). After centrifugation, the resulting 
supernatants were solubilized by treatment with Laemmli buffer at 100˚C for 5 min and 
separated by electrophoresis in 10% SDS-polyacrylamide gel. The electrophoresed proteins 
were transferred to polyvinylidene difluoride membranes with an electroblotter. After 
blocking with 5% skim milk, the membranes were probed with rabbit anti-phospho STAT3 
(Tyr705) antibody (Cell Signaling) (1:1000 dilution), rabbit anti-STAT3 antibody (Cell 
Signaling) (1:1000 dilution), rabbit anti-phospho c-Raf (Ser338) antibody (Cell Signaling) 
(1:200), rabbit anti-phospho MEK1/2 (Ser217/221) antibody (Cell Signaling) (1:500), rabbit 
anti-phospho p44/p42 MAP kinase (Thr202/Tyr204) antibody (Cell Signaling) (1:500), rabbit 
anti-p44/p42 MAP kinase antibody (Cell Signaling) (1:1000), goat anti-SOCS3 antibody (M-
20) (Santa Cruz Biotechnology) (1:100) or rabbit anti-β-actin antibody (clone AC-15) (Sigma) 
(1:5000 dilution) and treated with 1:1000 dilution HRP-conjugated anti-rabbit IgG (Santa 
Cruz Biotechnology) or HRP-conjugated donkey anti-goat IgG (Santa Cruz Biotechnology). 
The amount of HRP-conjugated IgG bound to each protein band was determined by LAS-
1000 (Fuji Film, Tokyo, Japan) and analyzed by Image Gauge (Fuji Film). The pixel density 
in each band was corrected by that in the control protein (STAT3, ERKs or β-actin). 
2.3 Immunostaining 
ES cells were washed with ice-cold TBS buffer (25 mM Tris, pH 7.4, 137 mM NaCl, and 2.68 
mM KCl), attached to microscope slides by Cytospin 4 centrifugation (Thermo Shandon, 
Pittsburgh, USA) (1,000 rpm, 5 min), and fixed with 4% paraformaldehyde for 15 min. They 
were permeabilized with 0.2% Triton X-100 for 5 min, and blocked with 1% bovine serum 
albumin for 30 min. For single staining, fixed cells were incubated with the rabbit anti-
phospho STAT3 (Tyr705) antibody (1:100) or rabbit anti-phospho p44/p42 MAP kinase 
(Thr202/Tyr204) antibody (1:100), rabbit anti-MAP2 antibody (1:400) (Santa Cruz 
Biotechnology), or rabbit anti-NeuroD2 antibody (1:100) (Sigma), and stained with FITC-
conjugated goat anti-rabbit IgG antibody (10 µg/ml) (ICN Pharmaceticals, USA).  For 
double staining, fixed cells were incubated with goat anti-SOCS3 antibody (M-20) (1:50) and 
stained with rhodamine-conjugated donkey anti-goat IgG (10 µg/ml) (Santa Cruz 
Biotehnology). Then, the samples were incubated with rabbit anti-phospho MEK1/2 
(Ser217/221) antibody (1:200) and stained with FITC-conjugated goat anti-rabbit IgG 
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antibody (10 µg/ml). For staining of nucleus, fixed cells were incubated with propidium 
iodide (1 µg/ml) (Sigma). Cells were visualized using a confocal laser scanning microscope 
(CLSM) (LSM510; Carl Zeiss, OberKochen, Germany) (Furuno et al., 1993; Nakanishi, 2003; 
Nakanishi and Furuno, 2008). FITC was excited at 488 nm by an argon ion laser and its 
fluorescence was detected through a long pass filter (> 505 nm) for the single staining. In the 
case of double staining, FITC and rhodamine were excited at 488 nm by an argon ion laser 
and at 543 nm by a He-Ne laser, respectively. Their fluorescence was detected through a 
band pass filter (505 - 530 nm) and a long pass filter (> 560 nm), respectively (Suzuki et al., 
2004; Furuno et al., 2005). 
2.4 Establishment of cell lines 
The ES cells (1 × 107 cells / 500 µl) were electroporated in cold K+-PBS with 30 µg of pTet-On 
plasmid DNA (Clontech Laboratories, Palo Alto, CA, USA) at 220 V and 475 µF using Gene 
Pulser (Bio-Rad, Richmond, CA). ES cells transfected with pTet-On were maintained in 
culture dishes for 48 h and were cloned by the selection with antibiotic G418 (Sigma). To 
investigate the expression of reverse tetracycline-controlled transactivator (rtTA) in 
monoclonal ES cells (rtTA-ES cells), luciferase was assayed after the transfection of the 
plasmid DNA containing tetracycline response element (TRE) to express luciferase (pTRE-
Luc) (Clontech). 
To obtain NeuroD2 cDNA, poly(A)+ RNA was prepared with a Quickprep Micro mRNA 
Purification Kit (Amersham Biosciences, Little Chalfont, Buckinghamshire, UK) from mouse 
cerebellum and served as templates for cDNA synthesis with SuperScript II RT (Invitrogen 
Corp., Carlsbad, CA, USA). The DNA sequences coding NeuroD2 (GEN Bank accession 
number: U58471) was obtained by RT-PCR with appropriate primer pairs, 5’-
GTCGACATGCTGACCCGCCTGTTC-3’ (sense; Acc I site is italicized) / 5’-
CCGCGGTCAGTTATGGAAAAATGCGTTGA-3’ (antisense; Sac II site is italicized) using a 
Taq polymerase EX-Taq (Takara, Tokyo, Japan). The PCR products were subcloned into a 
TA cloning vector pCRII (Invitrogen) and sequenced with an Applied Biosystems 3130xl 
genetic analyzer to verify the DNA sequence of NeuroD2. The full-length cDNA coding 
NeuroD2 was ligated with pTRE-Hyg2 expression vector (Clontech) at Acc I and Sac II sites 
(pTRE-ND2).  pTRE-ND2 plasmid DNA (30 µg) was electroporated to rtTA-ES cells (1 × 107 
cells/500 µl), and trandfected ES cells were cultured for 48 hr and then were selected by 
antibiotic Hygromycin B (Sugimoto et al., 2009). 
For genomic DNA PCR, genome DNA was isolated from ES cells (5 × 106 cells) with a Blood 
and Cell Culture Kit (Qiagen). For RT-PCR, mRNAs were purified from ES cells with a 
Quickprep Micro mRNA Purification Kit (Amersham Biosciences) and served as templates 
for cDNA synthesis with SuperScript II RT (Invitrogen). Genomic DNA and cDNA were 
amplified by PCR using appropriate primers and a Taq polymerase EX-Taq (Takara). 
The rtTA-ES cells were transfected with pTRE-Luc and were cultured for 48 hr in the 
presence or absence of doxycycline (1 µg/ml). Then, the cells were washed three times with 
PBS and lysed in a cell lysis buffer. The lysate was centrifuged at 12,000×g at 4 ˚C for 3 min 
and supernatant was subjected to a luciferase assay. The luciferase assay was carried out 
using a picagene luciferase assay kit (Toyo Ink, Tokyo, Japan). The relative light unit of 
chemiluminescence was measured with a luminometer (TD-20/20; Turner Designs; 
Sunnyvale, CA, USA) and the values were normalized to the amount of protein determined 
by BCA assay (Inoh et al., 2001). 
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2.5 Alkaline phosphatase assay 
After washing, ES cells were fixed with 4% paraformaldehyde for 15 min at 4 ˚C and stained 
with NBT-BCIP solution (Sigma). After incubation for 30 min at 37 ˚C, the reaction was 
stopped by EDTA (10 mM). The cells were washed with PBS and examined microscopically. 
2.6 Data analysis 
Data were presented as mean ± SEM.  In statistical analysis, data were analyzed by unpaired 
Student’s t-test, 2-tailed. P<0.05 were accepted as a level of statistically significant difference. 
3. Results 
3.1 The relationship between dephosphorylation of phospho-STAT3 and 
phosphorylation of ERKs 
To examine the relationship between activation of STAT3 and ERKs in the differentiation 
processes in mouse ES cells, we studied time-courses of phosphorylation of STAT3, ERKs, 
and Raf-1, which is a kinase that acts upstream of the ERK signaling cascade after the 
removal of LIF. In the presence of LIF, STAT3 was strongly phosphorylated in mouse ES 
cells, but Raf-1 and ERKs in the same cells were not phosphorylated, as described in 
previous papers (Qu et al., 1997; Burdon et al., 1999a; Matsuda et al., 1999; Jirmanova et al., 
2002; Chan et al., 2003; Yao et al., 2003). When LIF was removed from the culture medium, 
the level of phospho-STAT3 was decreased, but those of phospho-Raf-1, -MEK, and -ERKs 
were increased, as shown in Fig. 1a. The level of phospho-STAT3 reached the minimum at ~ 
4 h after the removal of LIF, and then, it increased again. In contrast, the phosphorylation of 
Raf-1 reached the maximum at ~ 4 h, and then decreased to the basal level. The 
phosphorylation of MEK occurred slowly, and ERKs were subsequently phosphorylated. 
These results suggested that the time-course of dephosphorylation of phospho-STAT3 was 
consistent with that of phosphorylation of Raf-1 and that the ERKs were phosphorylated 
with a lag period after the Raf-1 activation. In addition, immunostaining analysis showed 
that the fluorescence intensity of phospho-STAT3 in the nucleus in ES cells, which was high 
in the presence of LIF, decreased at 4 h and then became high at 72 h again after the removal 
of LIF. On the other hand, the fluorescence intensity of phospho-ERKs increased at 12 h, and 
fell to the basal level at 72 h. These immunostaining images were corresponding to the data 
of phosphorylation level observed by Western blotting. These suggested that the removal of 
LIF led to the differentiation of ES cells by the spatiotemporally balanced activation of 
STAT3 and ERKs. 
3.2 Link of STAT3 and ERKs signaling pathways 
Though the phosphorylation of ERKs was detected in ES cells after the removal of LIF, LIF 
was essentially known to activate the ERK signaling cascade. To study whether STAT3 and 
ERKs were phosphorylated by LIF stimulation in ES cells, we analyzed the 
phosphorylations of STAT3 and ERKs after the addition of LIF in ES cells which were pre-
cultured in the absence of LIF for 4 hr. LIF induced to the phosphorylation of ERKs as well 
as STAT3 within 10 min in LIF-starved ES cells. The LIF-mediated phosphorylation of 
STAT3 lasted 30 min, whereas that of ERKs was transient and almost disappeared at 30 min. 
Next, to examine the effects of signaling proteins in the ERK signaling cascade on the STAT3 
activation, we studied the LIF-mediated phosphorylations of STAT3 and ERKs in LIF-
starved ES cells pretreated with a MEK inhibitor PD98059 (20 µM) for 30 min (Alessi et al., 
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1995; Furuno et al., 2001). The pretreatment of PD98059 inhibited ERKs phosphorylation 
after LIF stimulation but not STAT3 phosphorylation. This suggested that the activation 
level of ERK did not affect the phosphorylation of STAT3. Next, to examine the effects of 
STAT3 transcriptional activity on the activation of ERKs in ES cells, we investigated the 
phosphorylation level of ERKs in ES cells cultured in the medium containing LIF and STAT3 
inhibitory peptide (STAT3IP) (10 µM), a membrane-permeable inhibitor of STAT3 
dimerization (Turkson et al., 2004). When ES cells were cultured in the presence of LIF in the 
medium containing STAT3IP (10 µM) for 4 days, the phosphorylation of ERKs was found to 
be accelerated. In contrast, the phosphorylation level of STAT3 was decreased. 
Immunostaining analysis also showed the increase in fluorescence intensity in the nucleus 
of phospho-ERKs and the decrease in that of phospho-STAT3 by the treatment with 
STAT3IP (10 µM) for 4 days. These indicated that STAT3IP led to the phosphorylation of  
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Fig. 1. Phosphorylation states of STAT3 and MAP kinase cascade. (a) The balanced 
phosphorylation of STAT3, Raf-1, MEK, and ERKs in ES cells after the removal of LIF. (b) 
The correspondence between the expression of SOCS3 and the phosphorylation of MEK 
after the removal of LIF. *P<0.05 and **P<0.01 compared to the value at 0 h. (c) The relation 
between the expression of SOCS3 and the phosphorylation of MEK at 4 h after the removal 
of LIF in individual ES cells. 
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ERKs and the dephosphorylation of STAT3, and that STAT3IP disrupted the balance of the 
activation of STAT3 and ERKs in ES cells cultured in LIF-containing medium. From the 
result, the reason why the phosphorylation level of ERKs was not detected in 
undifferentiated ES cells in the presence of LIF was guessed to be due to the high 
transcriptional activity of STAT3 mediated by LIF. 
3.3 Involvement of SOCS3 in STAT3IP-mediated ERKs phosphorylation 
We focused SOCS3 as a molecule involved in STAT3IP-mediated ERKs phosphorylation 
because the expression of SOCS3 was induced by cytokines including LIF probably through 
STAT3, and SOCS3 could also act to suppress ERK signaling by competing with SHP-2 for 
binding to the phosphotyrosine of gp130 (Bousquet et al., 1999; Duval et al., 2000; Nicholson 
et al., 2000; Schmitz et al., 2000). To confirm that LIF could induce the expression of SOCS3 
in ES cells, we examined the expression of SOCS3 after the addition of LIF to LIF-starved ES 
cells. The expression of SOCS3 was not detected in LIF-starved ES cells, but it increased 
gradually after the addition of LIF. The pretreatment of LIF-starved ES cells for 60 min with 
STAT3IP (10 µM) suppressed the LIF-mediated expression of SOCS3. 
Then, we studied the expression of SOCS3 in ES cells cultured in the presence of LIF. We 
found that SOCS3 was expressed in undifferentiated ES cells and that the removal of LIF 
reduced the expression of SOCS3 time-dependently, as shown in Fig. 1b. SOCS3 was almost 
undetectable in ES cells at 4 h after the removal of LIF. In contrast, the phosphorylation of 
MEK proceeded according to the decrease in expression of SOCS3 (Fig. 1b). In addition, 
double-immunostaining analysis of SOCS3 and phospho-MEK in individual ES cells also 
showed that SOCS3, which distributed on the plasma membrane, was diminished, and the 
phosphorylation of MEK increased in the cytoplasm at 4 h after the removal of LIF. In 
scatter plotting to analyze the correspondence between the expression of SOCS3 and the 
phophorylation of MEK in individual ES cells, it was shown that the phosphorylation of 
MEK proceeded in cells where the expression of SOCS3 was down-regulated 4 h after  
removal of LIF (Fig. 1c). These results strongly suggested that SOCS3, whose expression was 
regulated by STAT3 transcriptional activity, suppressed the activation of the ERK pathway. 
3.4 Establishment of ES cells stably transfected with pTet-On plasmid DNA 
As described above, the removal of LIF led to decrease the expression of SOCS3 and activate 
the ERK cascade in mouse ES cells. This phenomenon is probably the first step for ES cells to 
differentiate into many kinds of cell types, but it is also important to induce the 
differentiation into a specific target cell type in high efficiency. Here we tried to differentiate 
ES cells into neuronal cells using control system of NeuroD2 expression. First, to establish 
ES cells where the expression of NeuroD2 was regulated by doxycycline, mouse ES cell lines 
were transfected by electroporation with a pTet-On plasmid DNA. We obtained 21 
monoclonal ES cell lines resistant to G418 and investigated the transfection of pTet-On in 
genomic DNA. PCR for genomic DNA showed that the transfection of pTet-On was 
detected in the clone #9 ES cell (rtTA-ES cell), as shown in Fig. 2a. When pTRE-Luc plasmid 
DNA was temporally introduced to rtTA-ES cells, the clone #9 rtTA-ES cell had the highest 
luciferase activity after the addition of doxycycline among other clones. Thereafter, we 
transfected pTRE-ND2 plasmid DNA to the clone #9 rtTA-ES cell line and cultured them in 
the presence of Hygromycin B. After selection by Hygromycin B, polyclonal TRE-ND2-ES 
cells where pTRE-ND2 was stably transfected were established. Transfection of pTRE-ND2 
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in genomic DNA was detected in TRE-ND2-ES cells but not in wild type ES cells, as shown 
in Fig. 2b. TRE-ND2-ES cells also showed alkaline phosphatase activity and Oct3/4 
expression, which are features of an undifferentiated state of ES cells, similar to wild type ES 
cells. These findings indicate that TRE-ND2-ES cells were maintained in an undifferentiated 
state. 
3.5 Expression of NeuroD2 in ES cells after the addition of doxycycline 
Next, we confirmed the induction of NeuroD2 expression in TRE-ND2-ES cells by the 
addition of doxycycline by following mRNA and protein levels. A marked increase in 
mRNA for NeuroD2 was detected in TRE-ND2-ES cells at 24 h after doxycycline addition by 
RT-PCR. CLSM images showed that the treatment with doxycycline for 24 hr also led to 
express NeuroD2 protein in most TRE-ND2-ES cells, as shown in Fig. 2c. The NeuroD2 
expression was observed in TRE-ND2-ES cells treated for 48 hr to a similar extent. The 
results show that doxycycline induced the expression of NeuroD2 in TRE-ND2-ES cells. 
 
clone #9 #10 #13
Tet-On
Luciferase activity
(fold induction)
16.1 ± 3.2 0.7± 0.2 1.2± 0.2
TRE-ND2-ES wild type ES
TRE-ND2
NeuroD2
(a)
(b)
doxycyclin (-)
doxycyclin (+)
(c)
 
Fig. 2. Establishment of ES cell lines where the expression of NeuroD2 is regulated by 
doxycycline. (a) A genomic DNA PCR in ES cell clones transfected with pTet-On (rtTA-ES 
cells).  Fold induction of luciferase activity was shown as the value at 24 h after doxycycline 
addition divided by it at 0 h. (b) A genomic DNA PCR (upper) and an alkaline phosphatase 
staining (lower) in rtTA-ES cells transfected with pTRE-ND2 (TRE-ND2-ES cells) and wild 
type ES cells. (c) Immunostaining of NeuroD2 in TRE-ND2-ES cells. Fluorescence derived 
from NeuroD2 (green) and nucleus (red) was observed in cells treated without and with 
doxycycline for 24 h. 
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3.6 Differentiation into neurons after the addition of doxycycline 
To check that the induction of NeuroD2 expression elicits the neuronal differentiation, TRE-
ND2-ES cells were immunostained with MAP2, a marker protein of neurons. MAP2-positive 
neuronal cells were significantly developed without formation of EB after 7 days of 
doxycycline addition, although some spontaneous differentiation was observed in the 
absence of doxycycline. The fluorescence intensity derived from MAP2 was significantly 
increased by doxycycline, as shown in Fig. 3. Thus doxycycline-induced NeuroD2 
expression leads to neuronal development in TRE-ND2-ES cells. 
Finally, we investigated the period of treatment with doxycycline needed to induce clear 
evidence of neuronal differentiation. MAP2-positive cells were followed over 11 days of 
culturing; by day 3 of treatment there was sufficient evidence that differentiation into 
neurons had taken place. Treatment with doxycycline for 1 day did not induce the neuronal 
differentiation efficiently. In addition, CLSM images showed that NeuroD2 was localized in 
the cytoplasm but not in the nucleus on day 1, and thereafter proceeded gradually into the 
nucleus. The expression of NeuroD2 for an appropriate period (~3 days) was therefore 
necessary for the neuronal differentiation and its intracellular distribution also affected the 
efficiency of differentiation into neurons. 
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Fig. 3. Differentiation into neurons by doxycycline in TRE-ND2-ES cells. (Upper) 
Immunostaining of MAP2 in TRE-ND2-ES cells cultured in the presence of doxycycline (100 
µM). (Lower) Fluorescence intensity derived from MAP2 in region of interest (ROI) of CLSM 
images. Averaged fluorescence intensity in ROI was measured from 10 images of TRE-ND2-
ES cells cultured in the presence (closed squares) and absence (open triangles) of 
doxycycline. **P < 0.01 compared to cells without treatment of doxycycline. 
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4. Discussion 
LIF is a member of the family of IL-6 type cytokines, which includes IL-6, IL-11, oncostatin 
M, ciliary neurotrophic factor, and cardiotrophin-1, and leads to the activation of JAK-STAT 
and ERK pathways through LIFRβ-gp130 receptors. Because LIF also plays a crucial role in 
self-renewal and maintenance of pulripotency in mouse ES cells, it is widely used for their 
propagation. However, STAT3 is constitutively phosphorylated in undifferentiated ES cells 
in the presence of LIF and functions to maintain their undifferentiated state and 
pluripotency, but the phosphorylation of ERKs is not detected. The removal of LIF induces 
not only the dephosphorylation of phospho-STAT3 but also the phosphorylation of ERKs 
and directs ES cells to differentiate. Therefore, it has been considered that some important 
connections between the STAT3 and ERK pathways exist in ES cells, but the relationship 
between those pathways in the process of ES cell differentiation has not been analyzed in 
detail. 
At first, we found that the amount of phospho-STAT3 decreased at ~ 4 hr after the removal 
of LIF and then gradually increased at ~ 24 hr (Fig. 1). The phosphorylation of Raf-1 
occurred at ~ 4 hr, and thereafter MEK and ERKs were subsequently phosphorylated at 8 - 
12 h and immediately dephosphorylated. The time-courses of the phosphorylation levels of 
STAT3 and Raf-1 suggested the interaction between STAT3 and ERK pathways in ES cells.  
It was reported that the inhibition of ERKs activity resulted in the enhancement of STAT3-
mediated transcription in previous papers (Bonni et al., 1997; Ihara et al., 1997; Sengupta et 
al., 1998). However, the pretreatment with PD98059 affected neither the phosphorylation of 
STAT3 by LIF addition nor the dephosphorylation of phospho-STAT3 by LIF removal in our 
present condition. On the other hand, a membrane-permeable inhibitor of STAT3 
dimerization, STAT3IP, accelerated ERKs phosphorylation in ES cells cultured in the 
presence of LIF. These suggested that the phosphorylation of ERK did not affect STAT3 
activation, but that the transcriptional activity of STAT3 regulated the ERK activation. From 
these results, it was considered that the inactivation of STAT3 by the removal of LIF would 
trigger the activation of the ERKs pathway in ES cells (Miyazu et al., 2010). 
We showed here that the expression of SOCS3 depended on the presence of LIF in ES cells.  
The expression of SOCS3 was increased by the addition of LIF and decreased by the 
removal of LIF (Fig.1). SOCS3 is reported to exhibit inhibitory function of ERK signaling 
through the SHP-2 binding site of gp130 (Schmitz et al., 2000). The phosphorylation of MEK 
was actually promoted in ES cells expressing less SOCS3 in our present results (Fig. 1). In 
addition, it was reported that the absence of SOCS3 perturbed the balance of activation 
between STAT3 and ERK pathways and induced the reduction of self-renewal and the 
promotion of differentiation in ES cells (Forrai et al., 2006). Our data indicated the possibility 
that SOCS3, which is expressed by constitutively activated STAT3 in the presence of LIF in 
undifferentiated ES cells, suppressed the activation of ERK pathway, and that the reduction 
of SOCS3 expression as a result of dephosphorylation of phospho-STAT3 after LIF removal 
activated ERKs activation and became a trigger for differentiation in mouse ES cells. 
Because several signaling pathways are involved in propagation, maintenance of 
pluripotency, and differentiation in ES cells, its signaling and transcriptional network is very 
complicated (Chen et al., 2008). Other signaling molecules such as glycogen synthase kinase 
(GSK) 3 and transcriptional factors including Nanog, Oct-4, Smad1, and NF-κB in addition 
to ERKs, SOCS3, and STAT3 described in this paper, play important roles in mouse ES cells 
(Torres and Watt, 2008; Ying et al., 2008). On the other hand, it was reported that ERK 
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signals contributed to the maintenance of self-renewal, and LIF/STAT3 signaling was 
independent of maintenance of pluripotency in human ES cells (Okita and Yamanaka, 2006; 
Li et al., 2007). Accordingly, because the signaling pathway to maintain pluripotency and to 
induce differentiation in mouse ES cells may be different in human ES cells, the experiments 
to study the signaling pathway in human ES cells are necessary. In any case, the role of 
SOCS3 in ES cell differentiation needs to be defined in more detail, and our data strongly 
suggested that SOCS3 is intimately involved in the regulation of balanced activation 
between the STAT3 and ERK pathways in LIF signaling in mouse ES cells. 
In addition, we have tried to get ES cells to differentiate into neurons after the addition of 
doxycycline using NeuroD2, a bHLH transcriptional factor. NeuroD2 induces ectopic 
neurogenesis in the ectodermal cells in Xenopus embryos and neuronal differentiation in 
mammalian embryonal carcinoma cells (McCormick et al., 1996; Farah et al., 2000). We have 
shown that doxycycline induced the expression of NeuroD2 in TRE-ND2-ES cells and that 
the inducible NeuroD2 expression leads after several days to differentiation into neurons 
without formation of EBs. Addition of doxycycline significantly promotes neuronal 
differentiation in TRE-ND2-ES cells (see Fig. 2). About half the cells expressed NeuroD2 
after the addition of doxycycline, but the yield of MAP2-positive cells was 25 - 30%. It is 
known that extracellular matrices affect neural differentiation and growth, and that ES cells 
cultured on the dishes coated with laminin or fibronectin can be effectively differentiated 
into neurons (Czyz and Wobus, 2001; Andressen et al., 2005). In addition, several factors 
such as retinoic acid, basic fibroblast growth factor, sonic hedgehog, bone morphogenetic 
proteins, and Wnt can also play important roles in accelerating neuronal differentiation (Du 
and Zhang, 2004; Murashov et al., 2005). To study the essential role of NeuroD2 in neuronal 
differentiation, we cultured ES cells in gelatin-coated dishes in the absence of supplements 
such as growth factors and mitogen, in which the efficiency and specificity of differentiation 
was not completely satisfactory in view of transplantation and regenerative medicine. 
However, the combination of NeuroD2 expression and growth factor/mitogen addition 
does increase the specificity and efficiency of neural differentiation in ES cells. 
Doxycycline-induced neurons extended long neurites and formed dense neurite network. 
The number of MAP2-positive neurons reached a plateau at 3, while the MAP2-derived 
signal increased from 3 to 9 days. This means that ES cells are differentiated into neurons 
within 3 days after doxycycline addition, and that the differentiated neurons thereafter 
show neurite extension and network formation. However, although some ES cells 
spontaneously differentiated into neurons without doxycycline in this experimental 
condition, their neurites were thin and extend of their outgrowth was small. NeuroD2 was 
distributed in the cytoplasm of ES cells 1 day after the treatment with doxycycline, but if 
NeuroD2 could be translocated to the nucleus by some treatment (e.g. cytokines or growth 
factors), ES cells would be differentiated into neurons without the formation of EB, and raise 
the possibility of the induction of neuronal differentiation of ES cells in high efficiency by 
NeuroD2. 
5. Conclusion 
It is indicated that SOCS3 is involved in maintaining an undifferentiated state mediated by 
LIF and that the extrinsic expression of NeuroD2 efficiently induced differentiation into 
neurons in mouse ES cells. These findings provide the possibility to lead to the specific 
differentiation into target cell types for ES cells. 
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